Unknown

Dataset Information

0

Duokines: a novel class of dual-acting co-stimulatory molecules acting in cis or trans.


ABSTRACT: Co-stimulatory signals induced by ligands of the tumor necrosis factor superfamily (TNFSF) play a central role in T cell activation and have emerged as a promising strategy in cancer immunotherapy. Here, we established a novel class of bifunctional co-stimulatory fusion proteins with the aim to boost T cell activation at the level of T cell - antigen-presenting cell (APC) interaction. These novel dual-acting cytokine fusion proteins were created by connecting two different homotrimeric TNFSF ligands to form homotrimeric bifunctional molecules (Duokines) or by connecting single-chain derivatives of two different homotrimeric TNFSF with a single, flexible linker (single-chain Duokines, scDuokines). By linking the TNFSF ligands 4-1BBL, OX40L and CD27L in all possible combinations, cis-acting Duokines were generated that act on the same or adjacent T cells, while combining CD40L with 4-1BBL, OX40L and CD27L resulted in trans-acting Duokines acting simultaneously on APCs and T cells. In vitro, co-stimulation of T cells was seen for cis- and trans-acting Duokines and scDuokines in an antigen-independent as well as antigen-specific setting. Trans-acting molecules furthermore activated B cells, which represent a subclass of APCs. In a pilot experiment using the syngeneic B16-FAP mouse tumor model scDuokines displayed antitumoral activity in vivo in combination with a primary T cell-activating bispecific antibody, evident from reduced number of lung metastasis compared to the antibody-only treated group. Our data show that the bifunctional, co-stimulatory duokines are capable to enhance T cell-mediated anti-tumor immune responses, suggesting that they can serve as a new class of immuno-stimulatory molecules for use in cancer immunotherapy strategies.

SUBMITTER: Fellermeier-Kopf S 

PROVIDER: S-EPMC6140609 | biostudies-literature | 2018

REPOSITORIES: biostudies-literature

altmetric image

Publications

Duokines: a novel class of dual-acting co-stimulatory molecules acting in cis or trans.

Fellermeier-Kopf Sina S   Gieseke Friederike F   Sahin Ugur U   Müller Dafne D   Pfizenmaier Klaus K   Kontermann Roland E RE  

Oncoimmunology 20180801 9


Co-stimulatory signals induced by ligands of the tumor necrosis factor superfamily (TNFSF) play a central role in T cell activation and have emerged as a promising strategy in cancer immunotherapy. Here, we established a novel class of bifunctional co-stimulatory fusion proteins with the aim to boost T cell activation at the level of T cell - antigen-presenting cell (APC) interaction. These novel dual-acting cytokine fusion proteins were created by connecting two different homotrimeric TNFSF lig  ...[more]

Similar Datasets

| S-EPMC2708354 | biostudies-literature
| S-EPMC4096559 | biostudies-literature
| S-EPMC6391512 | biostudies-literature
| S-EPMC5441681 | biostudies-literature
| S-EPMC1474041 | biostudies-literature
| S-EPMC10093006 | biostudies-literature
| S-EPMC34625 | biostudies-literature
2015-06-05 | E-GEOD-69625 | biostudies-arrayexpress
| S-EPMC3742267 | biostudies-literature
| S-EPMC7834088 | biostudies-literature